The Food and Drug Administration last week refused to review Moderna’s application for its messenger RNA flu vaccine, in a move that the Cambridge biotech said came as a surprise.

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.